Home/Filings/4/0001708138-17-000013
4//SEC Filing

Terifay Robert J 4

Accession 0001708138-17-000013

CIK 0000872589other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:02 PM ET

Size

7.3 KB

Accession

0001708138-17-000013

Insider Transaction Report

Form 4
Period: 2017-08-10
Terifay Robert J
SVP Commercial
Transactions
  • Exercise/Conversion

    Common Stock

    2017-08-10$52.03/sh+1,921$99,95025,214 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2017-08-101,9210 total
    Exercise: $52.03Exp: 2021-12-16Common Stock (1,921 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,699
Footnotes (1)
  • [F1]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

Entity typeother

Related Parties

1
  • filerCIK 0001391382

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:02 PM ET
Size
7.3 KB